Liminal BioSciences Inc.
LMNL · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $622 | $12,213 | -$118,757 | -$206,753 |
| Dep. & Amort. | $1,120 | $4,344 | $8,447 | $9,906 |
| Deferred Tax | $286 | $118 | $16,535 | $87 |
| Stock-Based Comp. | $1,864 | $4,232 | $6,194 | $21,609 |
| Change in WC | -$42 | $1,424 | $1,129 | -$14,498 |
| Other Non-Cash | -$35,670 | -$121,934 | $10,535 | $90,259 |
| Operating Cash Flow | -$31,820 | -$99,603 | -$75,917 | -$99,390 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$19 | -$463 | -$2,046 | -$4,444 |
| Net Acquisitions | $0 | $173,357 | $4,555 | $43,958 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $3,838 | -$2,202 | -$204 | -$3,418 |
| Investing Cash Flow | $3,819 | $170,692 | $2,305 | $36,096 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $39,960 | $118,785 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$45,446 | -$8,424 | $57,405 | $117,919 |
| Financing Cash Flow | -$45,446 | -$8,424 | $57,405 | $117,919 |
| Forex Effect | $2,101 | $750 | -$3 | -$729 |
| Net Chg. in Cash | -$71,346 | $63,415 | -$16,210 | $53,896 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $108,490 | $45,075 | $61,285 | $7,389 |
| End Cash | $37,144 | $108,490 | $45,075 | $61,285 |
| Free Cash Flow | -$31,839 | -$100,066 | -$77,963 | -$103,834 |